Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexus Surgical and Medicare has the GF Score of 84, which implies that the company
might have
Good outperformance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Nexus Surgical and Medicare
might have
Good outperformance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Nexus Surgical and Medicare (BOM:538874) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Nexus Surgical and Medicare GF Score Related Terms
BOM:538874 vs MCK, COR, CAH: GF Score Comparison
For the Medical Distribution subindustry, Nexus Surgical and Medicare's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexus Surgical and Medicare GF Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Nexus Surgical and Medicare's GF Score distribution charts can be found below:
* The bar in red indicates where Nexus Surgical and Medicare's GF Score falls into.
Nexus Surgical and Medicare (BOM:538874) has a GF Score of 84 as of Aug. 15, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Nexus Surgical and Medicare and its competitors. This is 42% above median its historical median of 59.00. Over the past decade, Nexus Surgical and Medicare's GF Score has ranged from 11.00 to 86.00.
Is Nexus Surgical and Medicare's GF Score too high?
Nexus Surgical and Medicare's current GF Score of 84 is 42% above median its 10-year median of 59.00. Over the past 10 years, this metric has ranged from a low of 11.00 to a high of 86.00. Overall, Nexus Surgical and Medicare has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexus Surgical and Medicare's GF Score compare to MCK and COR?
Nexus Surgical and Medicare's GF Score of 84 can be compared against companies in the Medical Distribution industry. Historically, Nexus Surgical and Medicare's own GF Score has ranged from 11.00 to 86.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Nexus Surgical and Medicare and its competitors. Nexus Surgical and Medicare's current GF Score is 84, which is 42% above median its own 10-year median of 59.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus Surgical and Medicare stock overvalued right now?
Based on GuruFocus' analysis, Nexus Surgical and Medicare (BOM:538874) is currently considered Possible Value Trap. The stock's GF Value™ is ₹34.06, compared to a current price of ₹19.53 — trading 42.7% below its estimated fair value. The current GF Score is 84, which is 42% above median its 10-year median of 59.00. Nexus Surgical and Medicare's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Nexus Surgical and Medicare (BOM:538874), the current GF Score is 84 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus Surgical and Medicare (BOM:538874) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus Surgical and Medicare stock appears to be undervalued.
The current stock price of ₹19.53 is trading 42.7% below its estimated GF Value™ of ₹34.06.
GuruFocus considers Nexus Surgical and Medicare to be Possible Value Trap.
Key valuation signals for BOM:538874:
GF Score: 84 (42% above median its 10-year median of 59.00)
GF Value™: ₹34.06 vs. price of ₹19.53 (42.7% below fair value)
No single metric tells the full story. See the BOM:538874 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus Surgical and Medicare Ltd is involved in Importing and Marketing Quality Surgical and Pharmaceutical Products at an Economical Price. The Company is a wholesale dealer dealing in various sizes of disposal syringes (with and without needles) and pouches of various sizes used for the storage of sterilized equipment and materials. It operates in the segment of trading activities.
84GF Score
Get the complete analysis for BOM:538874
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538874 has been successfully added to your 
